ad

Kims Hospitals Share Price Target 2026 Analyst Forecast Bull and Bear Case

Sat Apr 25 2026

Kims Hospitals Share Price Target 2026 Analyst Forecast Bull and Bear Case
 

The KIMS Hospitals share price target for 2026 stands at Rs 2,210-2,540 as per analyst consensus implying 20-40% upside from the current market price of Rs 1,840. Investors tracking the KIMS Hospitals share price target 2026 need to understand the full picture: the growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios that will determine whether KIMS Hospitals (KIMS) achieves or misses this 12-month target. This article covers every dimension of the KIMS Hospitals share price target thesis updated April 2026.

Click Here Get Free Investment Predictions on Univest

Data from NSE/BSE and publicly available research. April 2026. Verify before investing. Track live KIMS Hospitals price, FII/DII flows and analyst targets on the Univest Screener.

Table of Contents

KIMS Hospitals Company Overview

Tap to Access Best Research Pieces on Univest

KIMS Hospitals (NSE: KIMS) is a significant listed company in India’s Hospital and Healthcare sector with a market capitalisation of Rs 12,400 crore. At CMP Rs 1,840 against a 52-week range of Rs 1,560 to Rs 2,400, the stock currently offers meaningful upside to the analyst consensus KIMS Hospitals share price target of Rs 2,210-2,540. The company has built defensible positions through consistent execution and deep sector expertise in the Hospital and Healthcare space.

India’s Hospital and Healthcare sector is growing structurally driven by urbanisation, rising incomes, government policy continuity, and the broad India growth narrative. KIMS Hospitals’s market position creates compounding runway that underpins the analyst KIMS Hospitals share price target 2026 consensus of Rs 2,210-2,540. FY27 is the year analysts expect operating leverage to translate revenue growth into meaningful PAT expansion, directly validating the current analyst target. For more share price target analysis across sectors, visit Univest Blogs.

Parameter Value
NSE Ticker KIMS
Sector Hospital and Healthcare
CMP (April 2026) Rs 1,840
52-Week High Rs 2,400
52-Week Low Rs 1,560
Market Cap Rs 12,400 crore
Trailing P/E 45x
12M Analyst Target Rs 2,210-2,540
Bull Case Target Rs 3,000
Bear Case Target Rs 1,350

Data from NSE/BSE and Screener.in. April 2026. Verify before investing.

Key Growth Catalysts for KIMS Hospitals Share Price Target in 2026

The KIMS Hospitals share price target of Rs 2,210-2,540 rests on several structural and near-term catalysts that analysts are actively monitoring. Understanding these drivers is essential for investors evaluating the risk-reward of the KIMS Hospitals share price target thesis.

FY27 Earnings Delivery and Revenue Acceleration

FY27 is the year where analysts expect KIMS Hospitals to deliver meaningful PAT growth the primary variable that bridges the gap between the current CMP of Rs 1,840 and the KIMS Hospitals share price target 2026 of Rs 2,210-2,540. After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, consensus projects KIMS Hospitals to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the KIMS Hospitals share price target consensus. Track Q4 results live on the Univest Screener.

Structural Sector Tailwinds in Hospital and Healthcare

India’s Hospital and Healthcare sector is expanding at 12-18% annually. KIMS Hospitals’s market position within this expanding sector creates compounding runway that directly supports the KIMS Hospitals share price target consensus of Rs 2,210-2,540. The company’s brand equity, operational depth, and customer relationships built over years are difficult to replicate providing a structural competitive moat that protects margins through competitive cycles. Discover top Hospital and Healthcare stocks with high potential on the Univest Screener.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle which commenced in 2026 reduces KIMS Hospitals’s borrowing costs and stimulates end-customer demand. Lower interest rates improve EBITDA-to-PAT conversion, directly expanding EPS and supporting the KIMS Hospitals share price target 2026 of Rs 2,210-2,540 by improving the earnings multiple justification. For capital-intensive businesses in the Hospital and Healthcare sector, falling rates are a meaningful margin tailwind that rational investors should factor into their analysis of the KIMS Hospitals share price target.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for KIMS Hospitals’s Hospital and Healthcare business. Regulatory clarity and government spending certainty reduce operating risk and improve earnings visibility directly supporting the KIMS Hospitals share price target 2026 bull case. Compare KIMS Hospitals with sector peers on the Univest Screener.

Improving Institutional Ownership and FII Flows

As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian mid and large cap companies are expected to recover through FY27. A sustained FII buying cycle would re-rate the Hospital and Healthcare sector broadly and directly support the KIMS Hospitals share price target of Rs 2,210-2,540 by expanding P/E multiples. Track live FII/DII activity for KIMS Hospitals on the Univest Screener.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and SEBI-registered research pieces.

KIMS Hospitals Share Price Targets Short-Term, 12-Month and Long-Term

Investors tracking the KIMS Hospitals share price target should distinguish between the near-term technical recovery target, the 12-month analyst consensus target, and the long-term fundamental scenario. All three are distinct and rest on different assumptions about catalyst delivery and macro conditions.

Short-Term KIMS Hospitals Share Price Target (3-6 Months)

The short-term KIMS Hospitals share price target is anchored to the 52-week low support zone near Rs 1,560 and the immediate resistance at the lower bound of the analyst target range. Near-term technical recovery is contingent on Q4 FY26 results being in-line or above expectations and macro sentiment stabilising after the US tariff announcement of April 2026. Subscribe to Univest Pro for SEBI-registered entry, target, and stop-loss recommendations Start Free Trial.

12-Month KIMS Hospitals Share Price Target 2026

The 12-month analyst consensus KIMS Hospitals share price target 2026 is Rs 2,210-2,540 implying 20-40% upside from the current CMP of Rs 1,840. This target assumes FY27 earnings delivery in-line with consensus projections, macro normalisation after US-India tariff resolution, and continued FII participation in quality Indian equities. Analysts at MOFSL, Kotak Institutional, YES Securities, and JM Financial maintain coverage on KIMS Hospitals. Track live targets on the Univest Screener.

Long-Term KIMS Hospitals Share Price Target (FY27-28)

For investors with a 2-3 year horizon, the long-term KIMS Hospitals share price target is Rs 3,000 in the bull case assuming full execution of the growth catalysts above, sustained sector expansion, and a stable macro environment. This long-term KIMS Hospitals share price target assumes no material deterioration in fundamentals and continued RBI rate support through the cycle. For more share price target analysis, visit Univest Blogs.

Bull Case and Bear Case for KIMS Hospitals Share Price Target

Bull Case KIMS Hospitals Share Price Target Rs 3,000

The bull case for the KIMS Hospitals share price target of Rs 3,000 materialises if FY27 earnings delivery exceeds consensus, macro conditions normalise faster than expected, and the Hospital and Healthcare sector benefits from strong FII re-rating. In this scenario, KIMS Hospitals trades at a premium multiple to peers justified by superior growth visibility, strong cash flows, and improving return ratios. This is not the base case but is achievable on full catalyst delivery within a 2-3 year horizon. Discover top stocks for your portfolio on the Univest Screener.

Bear Case KIMS Hospitals Share Price Target Rs 1,350

The bear case for the KIMS Hospitals share price target sees the stock testing the Rs 1,350 zone which aligns with the 52-week low support area. This scenario materialises if Q4 FY26 results disappoint significantly, FY27 guidance is cut below consensus, FII outflows persist into H2 2026, and the broader Hospital and Healthcare sector faces a valuation de-rating. The Rs 1,350 level represents the primary stop-loss reference for investors currently holding the stock. Track support and resistance levels on the Univest Screener.

Scenario Price Target Conditions
Bull Case Rs 3,000 FY27 beat, macro normalisation, sector re-rating
Base Case (Consensus) Rs 2,210-2,540 In-line FY27 earnings, tariff resolution, FII recovery
Bear Case Rs 1,350 FY27 guidance cut, persistent FII outflows, sector de-rating

Technical Levels Support and Resistance for KIMS Hospitals

From a technical standpoint, the KIMS Hospitals share price target analysis must account for the current positioning of the stock versus its key moving averages. KIMS Hospitals is trading at Rs 1,840 against a 52-week range of Rs 1,560 to Rs 2,400. The stock is below its 200-day moving average, reflecting the broader macro uncertainty from the April 2026 US tariff shock and sector-specific headwinds. Key support is at Rs 1,560 (52-week low zone) and key resistance is at the lower bound of the analyst target range. A confirmed close above resistance on volume would signal technical recovery toward the KIMS Hospitals share price target 2026 consensus of Rs 2,210-2,540. Set a live price alert for KIMS Hospitals on the Univest Screener.

Key Risks to the KIMS Hospitals Share Price Target 2026

US Tariff Macro Headwind

The 26% US reciprocal tariff announced on April 2, 2026 created FII outflow pressure across Indian equities including KIMS Hospitals. Prolonged US-India trade tension would reduce FY27 earnings estimates by 5-10% the key downside risk to the KIMS Hospitals share price target 2026 consensus of Rs 2,210-2,540. Monitor US-India trade negotiations closely as the primary macro variable for the KIMS Hospitals share price target thesis.

Valuation and Earnings Miss Risk

At 45x trailing P/E, KIMS Hospitals is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression the most immediate risk to the KIMS Hospitals share price target 2026. The Rs 1,350 52-week low zone is the key support and stop-loss reference for investors tracking the KIMS Hospitals share price target. Track quarterly earnings updates on the Univest Screener.

Competitive Pressure in Hospital and Healthcare

Intensifying competition in the Hospital and Healthcare space from domestic players scaling and global companies increasing India exposure could compress KIMS Hospitals’s pricing power and market share over the medium term. Monitor quarterly revenue growth and margin trends closely as leading indicators for the sustainability of the KIMS Hospitals share price target thesis. Subscribe to Univest Pro for SEBI-registered research on KIMS Hospitals.

FII Selling Pressure

Global risk-off events can trigger disproportionate institutional selling, disconnecting the stock price from fundamental value temporarily. FII exits create volatility that rational investors can use to accumulate quality businesses but only if the underlying fundamental thesis for the KIMS Hospitals share price target remains intact. Track FII/DII flows live on the Univest Screener.

Commodity and Input Cost Volatility

Raw material prices, energy costs, and currency moves can create quarterly earnings volatility for KIMS Hospitals. The company’s ability to pass through input cost increases to customers determines gross margin trajectory a key variable in modelling the KIMS Hospitals share price target 2026 consensus of Rs 2,210-2,540. Monitor quarterly gross margin trends as the leading indicator for fundamental health. Check Univest Screener for discovering Hospital and Healthcare stocks with high potential Explore Now.

Analyst Ratings and Institutional Positioning for KIMS Hospitals

The analyst consensus on the KIMS Hospitals share price target 2026 reflects a predominantly constructive view with the 12-month target range of Rs 2,210-2,540 implying 20-40% upside from the current CMP of Rs 1,840. Major brokerages including MOFSL, YES Securities, Kotak Institutional Equities, and JM Financial maintain coverage on KIMS Hospitals within the Hospital and Healthcare sector. The consensus rating is a mix of Buy and Hold with Buy-rated analysts anchoring the upper end of the KIMS Hospitals share price target range at Rs 3,000 and Hold-rated analysts at the lower end of Rs 2,210-2,540.

Q4 FY26 results (April-May 2026) are the primary near-term catalyst. A PAT beat with positive FY27 guidance triggers re-rating toward the upper end of the KIMS Hospitals share price target 2026 consensus. A miss triggers pressure toward the bear case of Rs 1,350. Track live analyst ratings and target revisions on the Univest Screener. For in-depth research reports from SEBI-registered analysts, download the Univest Android App or Univest iOS App.

How to Invest in KIMS Hospitals Step-by-Step Guide

  1. Research on Univest Screener: Visit univest.in/screeners and search KIMS to access live fundamentals, FII/DII flows, analyst ratings, and the latest KIMS Hospitals share price target data from SEBI-registered analysts.
  2. Open a Demat Account: Buy KIMS Hospitals (KIMS) through any SEBI-registered broker on NSE. Univest offers integrated broking and research Start here.
  3. Plan Your Entry: KIMS Hospitals at Rs 1,840 has key support near Rs 1,560. Plan entry near support with a stop-loss 8-10% below entry. First resistance is the lower bound of the KIMS Hospitals share price target range.
  4. Position Sizing: Allocate a maximum of 3-5% of your portfolio to any single stock. Never invest more than you can hold through 2+ years of volatility in the Hospital and Healthcare sector.
  5. Monitor with Univest App: Set a price alert at the Rs 1,560 support level and download the Univest App for SEBI-registered analyst research alerts on the KIMS Hospitals share price target.

FAQs on KIMS Hospitals Share Price Target 2026

What is the KIMS Hospitals share price target for 2026?

The KIMS Hospitals share price target 2026 is Rs 2,210-2,540 based on analyst consensus implying 20-40% upside from the current CMP of Rs 1,840. The bull case target is Rs 3,000 and the bear case is Rs 1,350. These are analyst estimates, not guaranteed returns. Verify all numbers before investing. Track live targets on the Univest Screener.

What is the KIMS Hospitals share price target for 2027?

For FY27-28, analysts project the KIMS Hospitals share price target toward Rs 3,000 in the bull case assuming full catalyst delivery, macro normalisation, and sustained sector expansion in the Hospital and Healthcare space. This is a scenario-based estimate contingent on FY27 earnings delivery and macro conditions. This does not constitute investment advice. Consult a SEBI-registered financial advisor.

Is KIMS Hospitals a good buy at the current price?

At Rs 1,840, KIMS Hospitals offers potential upside to the KIMS Hospitals share price target 2026 consensus of Rs 2,210-2,540. Whether it is a good buy depends on your risk tolerance, investment horizon, and portfolio context. The bull case to Rs 3,000 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 1,350 zone) materialises only if FY27 guidance disappoints significantly. Consult a SEBI-registered financial advisor. Get free research on Univest Click Here.

What are the main risks to the KIMS Hospitals share price target?

The key risks to the KIMS Hospitals share price target of Rs 2,210-2,540 include US tariff macro headwinds, valuation at 45x requiring consistent execution, competition in the Hospital and Healthcare sector, FII selling pressure, and earnings miss risk at Q4 FY26 or FY27 guidance. Monitor quarterly earnings closely and track FII/DII flows on the Univest Screener.

What are the key catalysts for the KIMS Hospitals share price target?

The primary catalysts for the KIMS Hospitals share price target 2026 include FY27 earnings delivery, structural sector growth in Hospital and Healthcare, RBI rate cut tailwinds, Budget 2026-27 policy support, and FII flow recovery as macro conditions normalise. Q4 FY26 results (April-May 2026) are the immediate trigger for re-rating toward the KIMS Hospitals share price target of Rs 2,210-2,540. Track all catalysts live on the Univest Screener.

Where can I track KIMS Hospitals live analyst targets?

Track the KIMS Hospitals share price target live including analyst ratings, FII/DII activity, quarterly results, and fundamentals on the Univest Screener at univest.in/screeners. Download the Univest Android App or Univest iOS App for real-time research alerts.

What is KIMS Hospitals’s 52-week high and low?

KIMS Hospitals’s 52-week high is Rs 2,400 and the 52-week low is Rs 1,560. The current CMP of Rs 1,840 offers meaningful potential recovery toward the KIMS Hospitals share price target 2026 of Rs 2,210-2,540 if the primary growth catalysts materialise over the next 12 months. Track live price data on the Univest Screener.

How to buy KIMS Hospitals shares?

Buy KIMS Hospitals (KIMS) through any SEBI-registered broker on NSE. Research the KIMS Hospitals share price target on the Univest Screener, set a price alert at the Rs 1,560 support level, and download the Univest App for SEBI-registered analyst research alerts. For more share price target analysis, visit Univest Blogs.

Disclaimer: Investment in the share market is subject to market risk. This article is for informational and educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of April 2026 and are subject to change. Verify all numbers before investing. Consult a SEBI-registered financial advisor before making any investment decisions. Investments in securities are subject to market risk. Please read all related documents before investing.

Recent Article

Kridhan Infra Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook

Krebs Biochemicals and Industries Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook

KRBL Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook

KPIT Technologies Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook

Kothari Sugars and Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook